Synthesis of N,N′-linked bisazaheterocycles with sulfonamide structure via oxidation of S,N-heteroaromatic cations

Synthesis

Volumn , Issue 7, 2008, Pages 1133-1141

  Zakharova, Valerija M ^a   González Tanarro, Camino M ^b   Gütschow, Michael ^b   Hennig, Lothar ^a   Sieler, Joachim ^a   Schulze, Bärbel ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

thiocyanatovinyl aldehydes; Isothiazolium salts; N,N linked bisazaheterocycles; N aminoheterocycles; Sultams

Indexed keywords

AMINOHETEROCYCLES; ISOTHIAZOLIUM SALTS; LINKED BISAZAHETEROCYCLES; SULTAMS; THIOCYANATOVINYL ALDEHYDES;

ALDEHYDES; CROSSLINKING; HYDROGEN PEROXIDE; MOLECULAR STRUCTURE; POSITIVE IONS; SYNTHESIS (CHEMICAL);

NITROGEN COMPOUNDS;

2,3 DIHYDRO 3 HYDROPEROXY 4,5 DIMETHYL 2 (PHTHALIMID 1 YL)ISOTHIAZOLE 1,1 DIOXIDE; 2,3 DIHYDRO 3 HYDROXY 4,5 DIMETHYL 2 (PHTHALIMID 1 YL)ISOTHIAZOLE 1,1 DIOXIDE; 2,3 DIHYDRO 3 HYDROXY 4,5 DIMETHYL 2 [2 METHYL 4 OXO 3(4H) QUINAZOLINYL]ISOTHIAZOLE 1,1 DIOXIDE; 2,3 DIHYDRO 3 HYDROXY 4,5 DIMETHYL 2 [4 OXO 3(4H) QUINAZOLINYL]ISOTHIAZOLE 1,1 DIOXIDE; 2,3,4,5,6,7 HEXAHYDRO 3 HYDROPEROXY 2 (PHTHALIMID 1 YL) 1,2 BENZISOTHIAZOLE 1,1 DIOXIDE; 2,3,4,5,6,7 HEXAHYDRO 3 HYDROXY 2 (PHTHALIMID 1 YL) 1,2 BENZISOTHIAZOLE 1,1 DIOXIDE; 4,5 DIMETHYL 2 (PHTHALIMID 1 YL)ISOTHIAZOLE 3(2H)ONE 1,1 DIOXIDE; 4,5 DIMETHYL 2 [2 METHYL 4 OXO 3(4H) QUINAZOLINYL]ISOTHIAZOLE 3(2H) ONE 1,1 DIOXIDE; 4,5 DIMETHYL 2 [4 OXO 3(4H) QUINAZOLINYL]ISOTHIAZOLE 3(2H) ONE 1,1 DIOXIDE; 4,5 DIMETHYL 2 [N (2 NITRO)BENZAMIDYL]ISOTHIAZOLE 3(2H) ONE 1,1 DIOXIDE; ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DICHROMATE POTASSIUM; HETEROCYCLIC COMPOUND; HYDROGEN PEROXIDE; ISOTHIAZOLIUM PERCHLORATE DERIVATIVE; LEUKOCYTE ELASTASE; N,N' BISAZAHETEROCYCLE DERIVATIVE; OXIDE; PERCHLORATE; PYRIDIUM DICHROMATE; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHORUS; ENZYME INHIBITION; NONHUMAN; OXIDATION;

EID: 42049106162     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1066984     Document Type: Article

References (40)

1. (a) Khalil, M. A.; El-Din, M. M. M. Alexandria J. Pharm. Sci. 1989, 3, 190;
2. Chem. Abstr. 1991, 114, 62064.
3. (b) Obniska, J.; Jurczyk, S.; Zeic, A.; Kaminski, K.; Tatarczynska, E.; Stachowicz, K. Pharm. Rep. 2005, 57, 170.
4. Effland, R. C.; Davis, L.; Olsen, G. E. Eur. Pat. Appl. EP 509400, 1991; Chem. Abstr. 1993, 118, 101970.
5. (a) Komatsu, M.; Yamamoto, S.; Ohshiro, Y.; Agawa, T. Heterocycles 1985, 23, 677.
6. (b) Bhalla, M.; Srivastava, V. K.; Bhalla, T. N.; Shanker, K. Arzneim. Forsch. 1993, 43, 595.
7. (c) Alcaide, B.; Miranda, M.; Perez-Castells, J.; Polanco, C.; Sierra, M. A. J. Org. Chem. 1994, 59, 8003.
8. (d) Tyagy, R.; Goel, B.; Srivastava, V. K.; Kumar, A. Indian J. Pharm. Sci. 1998, 60, 283.
9. (a) Hoda, A. A.; Sayed, A. S.; Momen, A. E. I. K.; Ahmed, S. A. Y. Phosphorous, Sulfur, Silicon Relat. Elem. 1992, 72, 237.
10. (b) Ibrahim, M. K. Egyptian J. Pharm. Sci. 1998, 39, 519.
11. Srivastava, V. K.; Singh, K. S.; Singh, S. N.; Fatima, N.; Chaterjee, R. K. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1991, 30, 859.
12. Angerbauer, R.; Huebsch, W.; Fey, P.; Bischoff, H.; Petzinna, D.; Schmidt, D.; Thomas, G. Eur. Pat. Appl. EP 339342, 1989; Chem. Abstr. 1990, 113, 115074.
13. Srivastava, V. K.; Singh, K. S.; Gulati, A.; Shanker, K. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1987, 26, 652.
14. (a) Reddy, G. M.; Bhavani, A. K. D.; Reddy, P. P.; Reddy, P. S. N. Synthesis 2002, 1311.
15. (b) Wang, J. H. Acc. Chem. Rec. 1970, 3, 90.
16. (c) Inbaraj, J. J.; Bilski, P.; Chignell, C. F. Photochem. Photobiol. 2002, 75, 107.
17. (d) Hawkins, C. L.; Davies, M. J. Chem. Res. Toxicol. 2002, 15, 183.
18. Martin, L.; Kosley, R. W. Jr.; Flanagan, D. M.; Kuerzel, G. U.; Nemoto, P. A.; Wettlaufer, D. G. US Patent 5274116, 1993; Chem. Abstr. 1994, 121, 280539.
19. (a) Martyn, D. C.; Moore, M. J.; Abell, A. D. Curr. Pharm. Des. 1999, 5, 405.
20. (b) Gütschow, M.; Pietsch, M.; Taubert, K.; Freysoldt, T. H. E.; Schulze, B. Z. Naturforsch., B: Chem. Sci. 2003, 58, 111.
21. Ashe, B. M.; Clark, R. L.; Jones, H.; Zimmerman, M. J. Biol. Chem. 1981, 256, 11603.
22. (a) Schulze, B.; Kirrbach, S.; Illgen, K.; Fuhrmann, P. Tetrahedron 1996, 52, 783.
23. (b) Hartung, C.; Illgen, K.; Sieler, J.; Schneider, B.; Schulze, B. Helv. Chim. Acta 1999, 82, 685.
24. (c) Taubert, K.; Sieler, J.; Hennig, L.; Findeisen, M.; Schulze, B. Helv. Chim. Acta 2002, 85, 183.
25. (d) Taubert, K.; Siegemund, A.; Eilfeld, A.; Baumann, S.; Sieler, J.; Schulze, B. Synthesis 2004, 2265.
26. (e) Siegemund, A.; Hartung, C.; Eilfeld, A.; Sieler, J.; Schulze, B. Z. Naturforsch., B: Chem. Sci. 2004, 59, 478.
27. Gütschow, M.; Pietsch, M.; Themann, A.; Fahrig, J.; Schulze, B. J. Enz. Inhib. Med. Chem. 2005, 20, 341.
28. Gelalcha, F. G.; Schulze, B. J. Org. Chem. 2002, 67, 8400.
29. Muehlstaedt, M.; Braemer, R.; Schulze, B. Z. Chem. 1976, 16, 49.
30. Zakharova, V.; Siegemund-Eilfeld, A.; Sieler, J.; Schulze, B. Z. Naturforsch., B: Chem. Sci. 2006, 61, 464.
31. Baumann, S.; Moeder, M.; Herzschuh, R.; Schulze, B. Chromatographia 2003, 57, 147.
32. Kolberg, A. Ph. D. Dissertation; Leipzig University: Germany, 1998.
33. -3.
34. -3.
35. -3.
36. Enders, D.; Plant, A.; Backhaus, D.; Reinhold, U. Tetrahedron 1995, 51, 10699.
37. Sheldrick, G. M. SHELX-97, A Program System for Solution and the Refinement of X-ray Crystal Structures; University of Göttingen: Germany, 1997.
38. The details of the structure analyses for compounds 15a, 18d, and 19b have been deposited at the Cambridge Crystallographic Data Centre with the numbers CCDC-651832, -651831 and -651833, respectively. The copies of the data can be obtained, free of charge, from CCDC, 12 Union Road, Cambridge, CB2 1EZ UK (fax: +44 1233 336033; e-Mail: deposit@ccdc.cam.ac.uk, internet: http://www.ccdc.cam.ac.uk).
39. Ellman, G. L.; Courtney, K. D.; Andres, V.; Feather-Stone, R. M. Biochem. Pharmacol. 1961, 7, 88.
40. Pietsch, M.; Gütschow, M. J. Med. Chem. 2005, 48, 8270.